Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 49
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Clin Pathol ; 62(5): 435-8, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-18996906

RESUMO

AIM: To measure pathologist workload in subspecialty dermatopathology. METHODS: Three subspecialty dermatopathologists, working in a university-affiliated laboratory, participated in a time-motion study during which they reported 2891 consecutive skin cases received from community-based dermatologists. All pathology reports were retrospectively reviewed and workload measured using the Royal College of Pathologists (RCPath) guidelines and the level 4 equivalent (L4E) method. RESULTS: The majority of dermatopathology cases were scored as low (32%) or intermediate (52%) complexity using the RCPath matrix. Only 16% of cases were considered high or very high complexity. The mean RCPath score per case was 2.68 units. Using L4E complexity levels, 83% of specimens were level 3, 15% were level 4, and only 2% were higher complexity (levels 5 and 6). Mean values for specimens/case, blocks/case, and slides/case were 1.31, 1.52, and 2.92, respectively. Time-motion analysis demonstrated a mean workload per hour of 16.3 cases, 21.3 specimens, 45.1 slides, 43.0 RCPath units, and 12.2 L4E. All three dermatopathologists reported >35 RCPath units per hour. CONCLUSIONS: The RCPath histopathology workload guidelines underestimate the workload achievable by an experienced dermatopathologist, and thus are not directly applicable to subspecialty dermatopathology practice. Hourly work rates 3-4 times that recommended by the RCPath workload matrix are routinely achievable, but extrapolation to yearly workload estimates requires detailed knowledge of practice pattern and time required for non-clinical duties such as teaching, research and administration.


Assuntos
Patologia Cirúrgica/organização & administração , Dermatopatias/patologia , Carga de Trabalho/estatística & dados numéricos , Alberta , Competência Clínica , Citodiagnóstico/estatística & dados numéricos , Humanos , Guias de Prática Clínica como Assunto , Estudos Retrospectivos , Sociedades Médicas , Estudos de Tempo e Movimento
2.
Br J Dermatol ; 158(1): 59-69, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17970804

RESUMO

BACKGROUND: In addition to an established role in the repair of postreplicative DNA errors, DNA mismatch repair (MMR) proteins also contribute to cellular responses to exogenous DNA damage. Previously, we have shown that Msh2-null mice display increased sensitivity to ultraviolet (UV) B-induced tumorigenesis, but squamous cell carcinomas (SCC) generated are microsatellite stable, suggesting a role for MMR other than postreplicative repair in UV-induced cutaneous tumour formation. OBJECTIVES: We questioned whether there was evidence of MMR dysfunction in human SCC, thus validating the mouse models of MMR-dependent UVB-induced skin cancer. METHODS: Using tissue microarrays we examined both nuclear and cytoplasmic levels of MMR proteins MSH2, MSH6, MSH3, MLH1 and PMS2 in more than 200 cases of cutaneous SCC and basal cell carcinoma (BCC). RESULTS: We found that subsets of these 10 MMR protein measures were increased in nonmelanoma skin cancer (NMSC) compared with normal epidermal samples; this was particularly true of SCC. In fact, based on post hoc tests and MMR protein distribution patterns, BCC was distinct from SCC. With the exception of nuclear MSH2, the BCC had lower levels of identified MMR protein measures than SCC. We believe this to be important because not only is SCC more aggressive than BCC, but evidence suggests that these two NMSC subtypes arise through different molecular pathways. CONCLUSIONS: In combination with previously established roles for MMR proteins in response to UVB-induced DNA damage, our data point towards an expanded perspective of the importance of MMR proteins in the suppression of UVB-induced tumorigenesis and, potentially, tumour behaviour.


Assuntos
Biomarcadores Tumorais/metabolismo , Carcinoma de Células Escamosas/genética , Reparo do DNA , Proteínas de Ligação a DNA/metabolismo , Proteínas de Neoplasias/metabolismo , Neoplasias Cutâneas/genética , Biomarcadores Tumorais/genética , Carcinoma Basocelular/genética , Carcinoma Basocelular/metabolismo , Carcinoma Basocelular/patologia , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/patologia , Núcleo Celular/metabolismo , Citoplasma/metabolismo , DNA de Neoplasias/genética , Humanos , Instabilidade de Microssatélites , Invasividade Neoplásica , Proteínas de Neoplasias/genética , Neoplasias Cutâneas/metabolismo , Neoplasias Cutâneas/patologia , Análise Serial de Tecidos/métodos
3.
Br J Dermatol ; 155(5): 988-93, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17034530

RESUMO

BACKGROUND: The risk of malignant melanoma associated with histologically dysplastic naevi (HDN) has not been defined. While clinically atypical naevi appear to confer an independent risk of melanoma, no study has evaluated the extent to which HDN are predictive of melanoma. OBJECTIVES: To estimate the risk of melanoma associated with HDN. Secondarily, the risk associated with number of naevi and large naevi is estimated. METHODS: We enrolled 80 patients with newly diagnosed melanoma along with 80 spousal controls. After obtaining information on melanoma risk factors and performing a complete cutaneous examination, the most clinically atypical naevus was biopsied in both cases and controls. Histological dysplasia was then assessed independently by 13 dermatopathologists (0, no dysplasia; 1, mild dysplasia; 2, moderate dysplasia; 3, severe dysplasia). The dermatopathologists were blinded as to whether the naevi were from melanoma subjects or controls. Multivariate analyses were performed to determine if there was an independent association between the degree of histological dysplasia in naevi and a personal history of melanoma. RESULTS: In persons with naevi receiving an average score of > 1 (i.e. naevi considered to have greater than mild histological dysplasia), there was an increased risk of melanoma [odds ratio (OR) 2.60, 95% confidence interval (CI) 0.99-6.86] which persisted after adjustment for confounders (OR 3.99, 95% CI 1.02-15.71). Very few dermatopathologists reliably graded naevi of subjects with melanoma as being more dysplastic than naevi of control subjects. Among the entire group, the interobserver reliability associated with grading histological dysplasia in naevi was poor (weighted kappa 0.28). CONCLUSIONS: HDN do appear to confer an independent risk of melanoma. However, this result may add more to our biological understanding of melanoma risk than to clinical assessment of risk, because HDN assessed by a single pathologist generally cannot be used to assess risk of melanoma. Future studies should be directed at establishing reproducible, predictive criteria for grading naevi.


Assuntos
Síndrome do Nevo Displásico/patologia , Melanoma/patologia , Neoplasias Cutâneas/patologia , Adulto , Estudos de Casos e Controles , Progressão da Doença , Feminino , Humanos , Masculino , Melanoma/etiologia , Pessoa de Meia-Idade , Variações Dependentes do Observador , Pigmentação , Fatores de Risco , Índice de Gravidade de Doença , Neoplasias Cutâneas/etiologia
4.
J Cutan Med Surg ; 7(2): 136-41, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12447621

RESUMO

BACKGROUND: Thrombospondins (TSPs) are recognized as important glycoproteins that regulate a wide variety of cell functions and interactions. TSPs in malignant tumors can both enhance and inhibit tumor progression, invasion, and metastasis, depending on cell type, stromal interactions, and microenvironment. These proteins are potential targets for anticancer therapy. OBJECTIVE: The aim of our article is to review the role of thrombospondin-1 (TSP1) in cutaneous melanoma. CONCLUSIONS: TSP1 expression is variable in melanoma cell lines and tumors. Similar to findings in other human cancers, expression of TSP1 by melanoma cells usually inhibits tumor progression via the antiangiogenic effect of TSP1. Conversely, stromal TSP1 overexpression in melanoma is a poor prognostic factor associated with decreased survival. Understanding the interactions of TSP1 with other melanoma- and matrix-associated proteins should provide new prognostic indices and possible therapeutic targets for melanoma treatment.


Assuntos
Melanoma/fisiopatologia , Neoplasias Cutâneas/fisiopatologia , Trombospondina 1/fisiologia , Genes p53/genética , Humanos , Integrinas/fisiologia , Melanoma/genética , Melanoma/metabolismo , Mutação , Neoplasias Cutâneas/genética , Neoplasias Cutâneas/metabolismo , Ativador de Plasminogênio Tipo Uroquinase/fisiologia
5.
Br J Dermatol ; 146(5): 786-91, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-12000374

RESUMO

BACKGROUND: p53 is a key regulator of the cellular stress response. p53 modulates the transcription of several genes. OBJECTIVES: To examine the influence of p53 on expression of heat shock protein 72 (HSP72). METHODS: Two model systems were used. (i) HSP72 expression was studied by Western blot on extracts from p53-proficient or p53-deficient primary mouse keratinocytes, and (ii) archival human anogenital skin from fibroepithelial polyps, human papillomavirus (HPV) 16/18-associated lesions or squamous cell carcinomas (SCCs) was subjected to immunostaining for HSP72. RESULTS: Basal HSP72 expression was higher in keratinocytes from p53-deficient than from p53-proficient mice. Immunostaining for HSP72 was higher in HPV 16/18 lesions and SCCs, which have reduced p53 protein. CONCLUSIONS: p53 status may influence the basal level of HSP72.


Assuntos
Genes p53/fisiologia , Proteínas de Choque Térmico/metabolismo , Queratinócitos/metabolismo , Animais , Western Blotting , Carcinoma de Células Escamosas/metabolismo , Técnicas de Cultura de Células , Proteínas de Choque Térmico HSP72 , Melanoma/metabolismo , Camundongos , Proteínas de Neoplasias/metabolismo , Papillomaviridae , Infecções por Papillomavirus/metabolismo , Neoplasias Cutâneas/metabolismo , Infecções Tumorais por Vírus/metabolismo
6.
J Cutan Pathol ; 29(3): 159-67, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11972713

RESUMO

BACKGROUND: Criteria for distinguishing between cutaneous lymphoid hyperplasia (CLH) and low-grade B-cell lymphoma are not well defined. We examined the hypothesis that the presence of a clonal B-cell population in heavy multinodular lymphoid infiltrates correlates with clinical presentation and outcome. METHODS: We identified 29 patients with skin lesions characterized histologically by a heavy dermal lymphocytic infiltrate with a multinodular architecture and extension into deep dermis and subcutaneous fat. Clonality was assessed immunophenotypically by light-chain restriction and also by analysis for IgH-gene rearrangement using PCR on DNA extracted from paraffin blocks. RESULTS: Follow-up (mean 80 months; median 45 months) was obtained in all patients. Twenty-four patients (83%) presented with a solitary lesion: only four had solitary recurrences, and none developed multiple synchronous lesions or systemic B-cell lymphoma. However, 9/24 of these solitary lesions (38%) were clonal by light-chain restriction or IgH PCR; 5/29 patients (17%) presented with multiple recurrent lesions and continued to develop lesions during the period of follow-up; 3/5 patients (60%) with multiple lesions demonstrated a B-cell clone. No patient developed systemic B-cell lymphoma. CONCLUSIONS: Heavy, multinodular cutaneous lymphoid infiltrates have an excellent prognosis. Multiple lesions at presentation are the best predictor of recurrent multiple lesions confined to the skin. The presence of a clonal B-cell population does not correlate with clinical presentation or histology, nor does it predict development of further lesions or systemic lymphoma.


Assuntos
Linfócitos B/patologia , Tecido Linfoide/patologia , Pseudolinfoma/patologia , Dermatopatias/patologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Células Clonais , DNA/análise , Feminino , Seguimentos , Rearranjo Gênico de Cadeia Pesada de Linfócito B/genética , Humanos , Hiperplasia , Masculino , Pessoa de Meia-Idade , Prognóstico , Pseudolinfoma/genética , Pseudolinfoma/terapia , Dermatopatias/genética , Dermatopatias/terapia , Resultado do Tratamento
7.
J Am Acad Dermatol ; 42(5 Pt 2): 895-6, 2000 May.
Artigo em Inglês | MEDLINE | ID: mdl-10767699

RESUMO

Pseudopelade is a rare self-limited hair disorder, resulting in cicatricial alopecia. It presents with skin-colored alopecic patches primarily involving the parietal and vertex portions of the scalp. This is a case report of a patient with pseudopelade that involves both his scalp and beard area.


Assuntos
Alopecia/patologia , Face/patologia , Couro Cabeludo/patologia , Adulto , Humanos , Masculino
8.
J Cutan Med Surg ; 3(6): 317-9, 1999 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-10575163

RESUMO

BACKGROUND: Epithelial elements, such as trichoepithelioma, are occasionally associated with melanocytic nevi. OBJECTIVE: A case of trichoepithelioma in association with cellular blue nevus is reported. METHODS AND RESULTS: A solitary, pigmented nodule was removed from the scalp of a middle-aged woman. Histopathologic examination demonstrated a circumscribed cellular blue nevus within which were embedded epithelial strands and cystic structures consistent with trichoepithelioma. CONCLUSION: Trichoepitheliomas have been described in relation to common acquired nevi, but an association with a blue nevus is rare. The intimate admixture of trichoepithelioma within the nodule of a nevus supports the concept of epithelial induction by melanocytic nevi.


Assuntos
Carcinoma/complicações , Nevo Azul/complicações , Nevo Pigmentado/complicações , Dermatoses do Couro Cabeludo/complicações , Carcinoma/patologia , Carcinoma/cirurgia , Feminino , Humanos , Pessoa de Meia-Idade , Nevo Azul/patologia , Nevo Azul/cirurgia , Nevo Pigmentado/patologia , Nevo Pigmentado/cirurgia , Dermatoses do Couro Cabeludo/patologia , Dermatoses do Couro Cabeludo/cirurgia
9.
Dermatol Surg ; 25(7): 582-6, 1999 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10469119

RESUMO

BACKGROUND: Numerous modalities may be used for skin resurfacing, including chemical peels, dermabrasion, and lasers. Each of these methods is associated with significant disadvantages. OBJECTIVE: The purpose of these initial studies was to determine the efficacy and safety of a new electrosurgical resurfacing system. Depth of cutaneous injury was also evaluated. METHODS: Postoperative scar resurfacing was performed on six patients in the initial feasibility study. Patients were evaluated with questionnaires, physician observations, and photographs. The histologic investigation evaluated depth of injury after resurfacing at various power settings and number of passes. RESULTS: Appearance of postoperative scars in all 6 patients was improved by electrosurgical resurfacing. The overall injury, residual thermal damage plus ablation, for all power levels and passes was 114.1 micrometer (mean) with a standard deviation of 60.7 micrometer. CONCLUSION: Electrosurgical resurfacing may become an effective and safe alternative to current resurfacing modalities.


Assuntos
Dermabrasão/instrumentação , Eletrocoagulação/instrumentação , Adulto , Idoso , Idoso de 80 Anos ou mais , Procedimentos Cirúrgicos Dermatológicos , Neoplasias Faciais/patologia , Neoplasias Faciais/cirurgia , Estudos de Viabilidade , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Cirurgia de Mohs , Complicações Pós-Operatórias/patologia , Complicações Pós-Operatórias/cirurgia , Pele/patologia , Neoplasias Cutâneas/patologia , Neoplasias Cutâneas/cirurgia
10.
Melanoma Res ; 9(2): 148-54, 1999 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10380937

RESUMO

We postulate that genes involved in the control of cell proliferation are important determinants of melanoma growth and/or transformation. Using Western blot analysis, we compared the expression of nine key cell cycle regulators in metastatic melanomas with that in benign acquired naevi. Among the cyclin-dependent kinases (CDKs) examined, CDK2 was consistently and significantly overexpressed (three- to eight-fold) in metastatic melanomas compared with naevi. CDK1 and CDK4 exhibited no significant difference in expression between benign naevi and metastatic melanomas. CDK6 expression was variable, with four out of 10 metastatic melanomas showing higher expression than naevi. All the cyclins examined, especially cyclins A and D, were expressed more in metastatic melanomas than in naevi. Cyclin E was not detected in benign naevi, but was easily detectable in most of the metastatic melanomas. In addition, there was significantly greater expression of CDC25A, a tyrosine phosphatase that activates CDK kinases, in the metastatic melanomas. Over-expression of CDK2, CDK6, CDC25A and cyclin A was confirmed in melanoma cell lines. These cell cycle regulators may play an important role in melanoma growth and/or transformation.


Assuntos
Quinases relacionadas a CDC2 e CDC28 , Proteínas de Ciclo Celular/metabolismo , Expressão Gênica , Melanoma/metabolismo , Neoplasias Cutâneas/metabolismo , Fosfatases cdc25 , Western Blotting , Células Cultivadas , Ciclina A/metabolismo , Ciclina E/metabolismo , Quinase 2 Dependente de Ciclina , Quinases Ciclina-Dependentes/metabolismo , Humanos , Proteínas Serina-Treonina Quinases/metabolismo , Proteínas Tirosina Fosfatases/metabolismo , Células Tumorais Cultivadas
11.
J Cutan Med Surg ; 3(5): 280-3, 1999 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10381953

RESUMO

BACKGROUND: The tumour suppressor, p53, is recognized as a crucial molecule in regulating cellular responses to various DNA-damaging agents. Very early on in the development of nonmelanoma cancers p53 is mutated or lost, suggesting that p53 is crucial in protecting normal keratinocytes from the harmful effects of ultraviolet (UV) radiation. OBJECTIVE: Using two mouse models, one with multiple copies of mutant p53 and the other a p53 "knockout," our laboratory has examined a role for p53 in UV-induced DNA damage and determined if these effects are differentiation dependent. CONCLUSION: We outline in this review a proposed model reflecting differentiation-dependent p53 regulation of UV-induced responses in keratinocytes. After exposure to UV, basal keratinocytes repair damaged DNA, whereas differentiating keratinocytes undergo cell death, both processes are regulated by p53.


Assuntos
DNA/efeitos da radiação , Epiderme/efeitos da radiação , Genes p53 , Queratinócitos/efeitos da radiação , Proteína Supressora de Tumor p53/efeitos da radiação , Raios Ultravioleta , Animais , Apoptose , Ciclo Celular , Reparo do DNA , Epiderme/patologia , Humanos , Camundongos , Proteína Supressora de Tumor p53/fisiologia
12.
J Cutan Med Surg ; 3(3): 148-52, 1999 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-10223831

RESUMO

BACKGROUND: Human T-cell lymphotropic virus I (HTLV- 1) infection can lead to myelopathy/tropical spastic paresis and adult T-cell leukemia/lymphoma (ATLL). Infection with HTLV-1 has also been associated with clinically significant immunosuppression. Crusted scabies, also known as Norwegian scabies, is an uncommon presentation of scabies that may occur in conjunction with immunosuppression. Although crusted scabies has been reported in association with HTLV-1 infection, to our knowledge it has never been described in association with HTLV-1 associated myelopathy. OBJECTIVE: The aim is to describe a case of HTLV-1 associated myelopathy and concomitant crusted scabies. METHODS: This article includes a case report and a literature review. CONCLUSIONS: Crusted scabies is reported in association with HTLV-1 infection with or without concomitant ATLL. Crusted scabies should be considered in the differential diagnosis of a generalized cutaneous eruption in an HTLV-1 positive patient. Patients with crusted scabies from an HTLV-1 endemic population should be rested for a possible HTLV-1 infection. These patients may be at increased risk of progressing to ATLL.


Assuntos
Vírus Linfotrópico T Tipo 1 Humano/isolamento & purificação , Paraparesia Espástica Tropical/complicações , Escabiose/etiologia , Adulto , Feminino , Humanos , Paraparesia Espástica Tropical/imunologia , Escabiose/imunologia
13.
J Cutan Med Surg ; 3(2): 112-4, 1998 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9822788

RESUMO

BACKGROUND: Multinucleate cell angiohistiocytoma (MCAH) is a rare cutaneous disorder that usually presents as papules or nodules. OBJECTIVE: This article reports a case of MCAH that appeared clinically as a large cutaneous plaque. METHODS AND RESULTS: A 74-year-old woman presented with a large painless, dusky red, indurated plaque measuring 12 x 6 cm on the trunk that was found on histopathologic examination to be a MCAH. Based on a literature review, this is the first reported case of MCAH presenting as a plaque rather than a papule or nodule. CONCLUSION: Multinucleate cell angiohistiocytoma may manifest clinically as a solitary cutaneous plaque.


Assuntos
Histiocitoma Fibroso Benigno/patologia , Neoplasias Cutâneas/patologia , Idoso , Feminino , Humanos , Imuno-Histoquímica
14.
Am J Dermatopathol ; 20(5): 443-7, 1998 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9790102

RESUMO

Empty spaces within the dermis of paraffin-embedded sections of skin have been attributed to fatty infiltration and postulated to originate from topical steroid administration or sebaceous gland rupture. We examined skin biopsy specimens exhibiting dermal vacuolation to determine whether this phenomenon was associated with specific skin diseases and to attempt to illuminate its etiology. Routine hematoxylin-eosin-stained sections from 26 formalin-fixed, paraffin-embedded biopsy specimens were examined. Histochemical stains for mucin and immunohistochemical staining for S100 protein and vascular markers were performed. Dermal vacuolation was characterized by empty spaces, 15-120 microm in diameter, in the superficial dermis, associated with either fibrosis/sclerosis or a lymphocytic infiltrate. There was no relationship to clinical findings, topical steroid treatment, or histologic diagnosis. There was no evidence of true adipocyte differentiation, and vascular markers were negative. Transmission electron microscopy showed nonmembrane-bound irregular spaces in the dermis. Dermal vacuoles likely represent an artifact of tissue fixation or processing and are unrelated to the underlying pathologic process. We propose the name pseudolipomatosis cutis, analogous to insufflation-induced colonic vacuolation, to distinguish this phenomenon from true dermal fatty infiltration and to emphasize its incidental, likely artifactual nature.


Assuntos
Lipomatose/patologia , Lectinas de Plantas , Dermatopatias/patologia , Adipócitos/citologia , Adipócitos/metabolismo , Tecido Adiposo/metabolismo , Adulto , Idoso , Idoso de 80 Anos ou mais , Antígenos CD34/análise , Artefatos , Criança , Derme/patologia , Derme/ultraestrutura , Fator VIIIa/análise , Feminino , Histocitoquímica , Humanos , Imuno-Histoquímica , Lectinas/análise , Masculino , Microscopia Eletrônica , Pessoa de Meia-Idade , Estudos Prospectivos , Estudos Retrospectivos , Proteínas S100/análise , Pele/patologia , Pele/ultraestrutura , Vacúolos/ultraestrutura
15.
J Burn Care Rehabil ; 19(5): 382-5, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9789170

RESUMO

Reports exist in the literature where metastasis or inadvertent operative spread has transferred excised squamous cell carcinoma, keratoacanthoma, and melanoma to skin graft donor sites. This report examines the potential for the reverse to occur. A de novo squamous cell carcinoma developing in a split-thickness skin graft donor site within 5 weeks of harvest for acute burn coverage is presented. As repeated harvesting from this site was performed, the transplantation of carcinoma could have occurred. The etiology of this squamous cell carcinoma, the risk of transplantation, and the 18-month follow-up are presented.


Assuntos
Carcinoma de Células Escamosas/etiologia , Neoplasias Cutâneas/etiologia , Transplante de Pele/patologia , Doença Aguda , Queimaduras/cirurgia , Carcinoma de Células Escamosas/patologia , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Invasividade Neoplásica , Transplante de Neoplasias , Fatores de Risco , Neoplasias Cutâneas/patologia , Fatores de Tempo , Cicatrização
16.
J Invest Dermatol ; 111(2): 194-8, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9699716

RESUMO

In response to ultraviolet radiation (UVR), skin keratinocytes increase expression of heat shock proteins that can protect cells from stress-induced damage. This heat shock response is known to be transcriptionally regulated in eukaryotic cells exposed to certain forms of environmental stress. In the skin, absorption of ultraviolet B light occurs primarily in the epidermis, and therefore, using primary cultures of normal human epidermal keratinocytes, we have examined whether transcriptional activation of the hsp72 gene occurs following UVB irradiation. Cultured keratinocytes were exposed to UVB (290-320 nm, 300 J per m2) and then incubated at 37 degrees C for various intervals before harvesting. Immediately following UV exposure, the heat shock transcription factor 1 (HSF1) dissociated from HSP72-HSF1 complexes, underwent trimerization and phosphorylation, and demonstrated DNA binding activity to the heat shock element in the promoter region of the hsp72 gene. UVB also increased hsp72 mRNA, with peak levels observed 1-3 h post-UVR. HSP72 protein was constitutively expressed in keratinocytes, and its expression was increased by UVB, with maximum levels at 6 h post-UVR. The stress response may be extremely important in the protection of human skin from UVB radiation, and modulation of heat shock protein expression and/or function offers a potential therapeutic target in the prevention of photoaging and skin cancer.


Assuntos
Proteínas de Ligação a DNA/fisiologia , Regulação da Expressão Gênica , Proteínas de Choque Térmico/genética , Queratinócitos/efeitos da radiação , Raios Ultravioleta , Células Cultivadas , Proteínas de Choque Térmico HSP72 , Fatores de Transcrição de Choque Térmico , Humanos , Queratinócitos/metabolismo , RNA Mensageiro/análise , Fatores de Transcrição
17.
Am J Pathol ; 153(2): 579-85, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9708817

RESUMO

Previous studies from our laboratory, using p53 transgenic mice, have suggested that ultraviolet (UV) light-induced keratinocyte apoptosis in the skin is not affected by overexpression of mutant p53 protein. To further elucidate a possible role for p53 in UV-induced keratinocyte cell death, we now examine apoptosis in skin and isolated keratinocytes from p53 null (-/-) mice and assess the influence of cell differentiation on this process. In vivo, using this knockout model, epidermal keratinocytes in p53-/- mice exhibited only a 5.2-fold increase in apoptosis after 2000 J/m2 UVB irradiation compared with a 26.3-fold increase in normal control animals. If this p53-dependent apoptosis is important in elimination of precancerous, UV-damaged keratinocytes, then it should be active in the undifferentiated cells of the epidermal basal layer. To test this hypothesis, we examined the effect of differentiation on UV-induced apoptosis in primary cultures of murine and human keratinocytes. Apoptosis was p53-independent in undifferentiated murine keratinocytes, which exhibited relative resistance to UVB-induced killing with only a 1.5-fold increase in apoptosis in p53+/+ cells and a 1.4-fold increase in p53-/- cells. Differentiated keratinocytes, in contrast, showed a 9.4-fold UVB induction of apoptosis in p53+/+ cells, almost three times the induction observed in p53-/- cells. This UV-induced difference in apoptosis was observed when keratinocytes were cultured on type IV collagen substrate, but not on plastic alone. Western blotting of UV-irradiated, differentiated keratinocytes did not support a role for either Bax or Bcl-2 in this process. In support of these findings in mice, cell death in human cultured keratinocytes also occurred in a differentiation-associated fashion. We conclude that p53-induced apoptosis eliminates damaged keratinocytes in the differentiated cell compartment, but this mechanism is not active in the basal, undifferentiated cells and is therefore of questionable significance in protection against skin cancer induction.


Assuntos
Apoptose , Genes p53/fisiologia , Queratinócitos/patologia , Raios Ultravioleta/efeitos adversos , Animais , Diferenciação Celular , Células Cultivadas , Colágeno/fisiologia , Humanos , Imuno-Histoquímica , Queratinócitos/metabolismo , Queratinócitos/efeitos da radiação , Camundongos , Camundongos Knockout , Proteínas Proto-Oncogênicas/biossíntese , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Proteína X Associada a bcl-2
18.
Clin Cancer Res ; 4(8): 1865-71, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9717813

RESUMO

Metastatic malignant melanoma (MM) is usually incurable and responds poorly to chemotherapy. Because many cytotoxic drugs cause cell death by inducing apoptosis, an imbalance of apoptosis regulatory proteins may contribute to MM treatment resistance. We have previously shown reduced expression of Bcl-2 protein, a negative regulator of apoptosis, in MM as compared with benign nevi. It is hypothesized that other apoptosis regulators may be involved in survival of MM cells. We examined the expression of Bax, Bcl-2, Bcl-X, and Mcl-1 in human benign nevi, primary MM, and metastatic MM using immunohistochemistry. Results were confirmed with Western blotting. The proapoptotic protein, Bax, was surprisingly overexpressed in all MM samples compared with benign nevi. Interestingly, in most MM samples there was overexpression of Mcl-1 or Bcl-XL, both negative regulators of apoptosis. Increased expression of Mcl-1 and Bcl-XL was first observed in thin primary melanomas, suggesting that up-regulation of these proteins represents a relatively early event associated with malignant transformation in MM. As published previously, the majority of primary and metastatic MM exhibited reduced Bcl-2 levels. We conclude that the apoptosis inhibitors Bcl-XL or Mcl-1, alone or in combination, may circumvent the normal cell death pathway, contributing to the pathogenesis and treatment resistance in metastatic MM.


Assuntos
Apoptose/fisiologia , Melanoma/metabolismo , Proteínas de Neoplasias/fisiologia , Proteínas Proto-Oncogênicas c-bcl-2/fisiologia , Neoplasias Cutâneas/metabolismo , Humanos , Immunoblotting , Imuno-Histoquímica , Melanoma/patologia , Proteína de Sequência 1 de Leucemia de Células Mieloides , Proteínas de Neoplasias/biossíntese , Proteínas Proto-Oncogênicas/biossíntese , Proteínas Proto-Oncogênicas/fisiologia , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Neoplasias Cutâneas/patologia , Proteína X Associada a bcl-2 , Proteína bcl-X
19.
J Cutan Med Surg ; 3(1): 16-20, 1998 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9677255

RESUMO

BACKGROUND: p53 protects the integrity of the genome by inducing programed cell death or by promoting DNA repair. We have previously shown that loss or mutation of p53 leads to reduced DNA repair in keratinocytes. OBJECTIVE: The hypothesis that p53 regulates repair of ultraviolet light-induced epidermal DNA damage in vivo was tested in mice. METHODS: An immunohistochemical assay for pyrimidine dimers and 6-4 photoproducts was performed on ultraviolet-irradiated skin from p53 null (-/-) and wild type (+/+) mice. Immunostaining for photoproducts was quantified using computer-assisted imaging. The level of DNA repair was then expressed as the percentage of positive cells remaining as compared to the zero hour time point. RESULTS: p53+/+ mouse skin exposed to 1000 J/m2 retained ' 25% of epidermal cyclobutane dimers at 48 h, whereas approximately 50% remained in p53-/- cells. Using the same UV dose, p53+/+ mice retained 20% of detectable 6-4 photoproducts by 24 h, whereas about 50% remained in epidermal cells of p53-deficient mice. CONCLUSION: Using in situ labelling of UV-damaged cells, we confirm our earlier conclusion that p53 regulates DNA repair within the epidermis after exposure to UV light.


Assuntos
Reparo do DNA/fisiologia , Genes p53/fisiologia , Queratinócitos/metabolismo , Queratinócitos/efeitos da radiação , Animais , Anticorpos Monoclonais , Apoptose/efeitos da radiação , Diferenciação Celular/efeitos da radiação , Processamento de Imagem Assistida por Computador , Imuno-Histoquímica , Queratinócitos/citologia , Camundongos , Camundongos Endogâmicos C57BL , Raios Ultravioleta/efeitos adversos
20.
J Cutan Pathol ; 24(5): 265-71, 1997 May.
Artigo em Inglês | MEDLINE | ID: mdl-9194578

RESUMO

p21(WAF1/CIP1) (p21) is an inhibitor of cyclin-dependent kinases recently identified as the downstream effector of wild-type p53-mediated cell cycle arrest. The gene coding for p21 may function as a negative regulator of melanoma growth, progression, and metastasis. Using immunohistochemistry and Western blotting, we investigated the expression of p21 in human melanocytic proliferations. Immunohistochemical staining was performed on 13 common acquired nevi, 12 dysplastic nevi, 23 primary malignant melanomas, and 12 metastatic melanomas. Common acquired nevi showed minimal p21 staining (1.8+/-0.3%, mean+/-SEM). The percentage of positive nuclei was slightly elevated in dysplastic nevi (8.9+/-1.7%). Both primary malignant melanoma (29+/-3%) and metastatic melanoma (33+/-5%) demonstrated a significantly increased number of p21-positive nuclei compared to benign lesions (p<0.001). p21 was strongly expressed even in actively proliferating lesions as confirmed by MIB-1 labelling, and although the majority of p21-positive cells likely represent a non-proliferating population, staining was occasionally observed in cells undergoing mitosis, suggesting abnormal function of this cell cycle inhibitor in malignant melanoma. Overexpression of p21 in metastatic melanoma compared to common acquired nevi was confirmed by Western blot analysis of human tumor samples. These findings suggest that increased p21 expression relative to benign nevi is not sufficient to control melanoma growth in vivo.


Assuntos
Quinases Ciclina-Dependentes/antagonistas & inibidores , Ciclinas/metabolismo , Regulação Neoplásica da Expressão Gênica , Melanoma/genética , Neoplasias Cutâneas/genética , Western Blotting , Inibidor de Quinase Dependente de Ciclina p21 , Humanos , Imuno-Histoquímica , Melanoma/patologia , Metástase Neoplásica , Neoplasias Cutâneas/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...